A recent ruling over whether a drug trial carried out under contract was a new knowledge generating activity for R&D tax incentive purposes has implications for all contracted tech development. Earlier this year, the Administrative Appeals Tribunal (AAT) ruled on a case involving a pharmaceutical company that provides developmental...